$GLLA The company was also working to get ahead of their peers by introducing a whole new series of products before the August deadline by the FDA, which limits the introduction of new products without prior FDA approval. Gilla was able to do this in part because they own their laboratory and production facilities, an integral part of their 62% gross margins last quarter.

https://finance.yahoo.com/news/small-cap-stoc...00038.html